Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 78, Issue 2, 2007, Pages 246-253

  Bianchi, Cristina ^a   Penno, Giuseppe ^a   Pancani, Francesca ^a   Civitelli, Alessia ^a   Piaggesi, Alberto ^a   Caricato, Francesco ^a   Pellegrini, Giovanni ^b   Del Prato, Stefano ^a   Miccoli, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Central Laboratory   (Italy)

Author keywords

Non traditional cardiovascular risk factors; Peripheral arterial disease; Type 2 diabetes

Indexed keywords

FIBRINOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ANKLE BRACHIAL INDEX; ANKLE PRESSURE; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PULSE PRESSURE; RISK FACTOR; SCREENING TEST; SMOKING; STATISTICAL SIGNIFICANCE;

AGED; ANKLE; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; FIBRINOGEN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; PULSE; RISK FACTORS; SMOKING;

EID: 34548818737     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.03.020     Document Type: Article

References (54)

1. Donahue R.P., and Orchard T.J. Diabetes mellitus and macrovascular complications-an epidemiological perspective. Diabetes Care 15 (1992) 1141-1149
2. Adler A.I., Boyko E.J., Ahroni J.H., and Smith D.G. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 22 (1999) 1029-1035
3. Walters D.P., Gatling W., Mullee M.A., and Hill R.D. The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabetes Med. 9 (1992) 710-715
4. Wild S.H., Byrne C.D., Smith F.B., Lee A.J., and Fowkes F.G.R. Low Ankle-Brachial Pressure Index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study. Diabetes Care 29 (2006) 637-642
5. Norman P.E., Davis W.A., Bruce D.G., and Davis T.M. Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 29 (2006) 575-580
6. MacGregor A.S., Price J.F., Hau C.M., Lee A.J., Carson M.N., and Fowkes F.G. Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. The Edinburgh Artery Study. Diabetes Care 22 (1999) 453-458
7. Al-Delaimy W.K., Merchant A.T., Rimm E.B., Willett W.C., Stampfer M.J., and Hu F.B. Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am. J. Med. 116 (2004) 236-240
8. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 26 (2003) 3333-3341
9. Leng G.C., Fowkes F.G.R., Lee A.J., Dunbar J., Housley E., and Ruckley C.V. Use of ankle brachial pressure index to predict cardiovascular events and death: a Cohort Study. BMJ 313 (1996) 1440-1444
10. Lijmer J.G., Hunink M.G., van den Dungen J.J., Loonstra J., and Smit A.J. ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med. Biol. 22 (1996) 391-398
11. Boizel R., Benhamou P.Y., Lardy B., Laporte F., Foulon T., and Halimi S. Ratio of triglycerides to HDL cholesterol is an indicatore of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 23 (2000) 1679-1685
12. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D., and Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann. Intern. Med. 130 (1999) 461-470
13. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), Final report, Circulation 106 (2002) 3143-3421.
14. Haffner S.M. Management of dyslipidemia in adults with diabetes. Diabetes Care 26 Suppl. 1 (2003) S83-S86
15. Bennett P.H., Haffner S., Kasiske B., Keane W.F., Mogensen C.E., Parving H.H., et al. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the scientific advisory board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am. J. Kidney Dis. 25 (1995) 107-112
16. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann. Intern. Med. 139 (2003) 137-147
17. Elhadd T.A., Robb R., Jung R.T., Stonebridge P.A., and Belch J.J.F. Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Pract. Diabetes Int. 16 (1999) 163-166
18. Rhee S.L., Guan H., Liu Z.M., Cheng S.W., Waspadji S., Palmes P., et al. Multi-country study on the prevalence and clinical features of peripheral arterial disease in asian type 2 diabetes patients at high risk of atherosclerosis. Diabetes Res. Clin. Pract. 76 (2007) 82-92
19. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
20. Katsilambros N.L., Tsapogas P.C., Arvanitis M.P., Tritos N.A., Alexion P., and Rigas K.L. Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic persons. Diabetes Med. 13 (1996) 243-246
21. Janka H.U., Standl E., and Mehnert H. Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the Doppler ultrasonic technique. Diabetes Care 3 (1980) 207-213
22. Maser Jr. R.E., Wolfson S.K., Ellis D., Stein E.A., Drash A.L., Becker D.J., et al. Cardiovascular disease and arterial calcification in insulin dependent diabetes mellitus: interrelations and risk factor profiles, Pittsburgh Epidemiology of Diabetes Complications Study-V,. Arterioscler Thromb. 11 (1991) 958-965
23. Kallio M., Forsblom C., Groop P.H., Groop L., and Lepantalo M. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care 26 (2003) 1241-1245
24. Wattanakit K., Folsom A.R., Selvin E., Weatherley B.D., Pankow J.S., Brancati F.L., et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 180 (2005) 389-397
25. Faglia E., Caravaggi C., Marchetti R., Mingardi R., Morabito A., Piaggesi A., et al., For the SCAR (Screening for ARteriopaty) Study Group. Screening for peripheral arterial disease by means of the ankle-brachial index in newly diagnosed type 2 diabetic patients. Diabetes Med. 22 (2005) 1310-1314
26. Thavendiranathan P., Bagai A., Brookhart M.A., and Choudhry N.K. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 166 (2006) 2307-2313
27. Chalmers J. Comparison of various blood pressure lowering treatments on the primary prevention of cardiovascular outcomes in recent randomised clinical trials. Clin. Exp. Hypertens 26 (2004) 709-719
28. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348 (2003) 383-393
29. Hackam D.G., and Anand S.S. Emerging risk factors for atherosclerotic vascular disease. A critical review of the evidence. JAMA 290 (2003) 932-940
30. Muntner P., He J., Chen J., Fonseca V., and Whelton P.K. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III). Ann. Epidemiol. 14 (2004) 686-695
31. Moss S.E., Klein R., and Klein B.E. The 14-year incidence of lower-extremity amputations in a diabetic population: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 22 (1999) 951-959
32. Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 19 (1996) 607-612
33. 1c level and peripheral arterial disease. Diabetes Care 28 (2005) 1981-1987
34. Adler A.I., Stevens R.J., Neil A., Stratton I.M., Boulton A.J., and Holman R.R. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25 (2002) 894-899
35. 1c and peripheral arterial disease in diabetes: the atherosclerosis risk in communities study. Diabetes Care 29 (2006) 877-882
36. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
37. Lee A.J., MacGregor A.S., Hau C.M., Price J.F., Rumley A., Lowe G.D., et al. The role of haematological factors in diabetic peripheral arterial disease: the Edinburgh Artery Study. Br. J. Haematol. 105 (1999) 648-654
38. Smith F.B., Lowe G.D., Lee A.J., Rumley A., Leng G.C., and Fowkes F.G. Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication. J. Vasc. Surg. 28 (1998) 129-135
39. O'Rourke M.F., and Frohlich E.D. Pulse pressure: is this a clinically useful risk factor?. Hypertension 34 (1999) 372-374
40. Cockcroft J., Wilkinson I.B., Evans M., McEwan P., Peters J.R., Davies S., et al. Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus. Am. J. Hypertens 18 (2005) 1463-1467
41. Tseng C.H. Pulse pressure as a risk factors for peripheral vascular disease in type 2 diabetic patients. Clin. Exp. Hypertens 25 (2003) 475-485
42. Berneis K., Jeanneret C., Muser J., Felix B., and Miserez A.R. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes. Metabolism 54 (2005) 227-234
43. Tseng C.H. Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with type 2 diabetes. Diabetes Med. 21 (2004) 724-729
44. A. Shankar, B.E. Klein, F.J. Nieto, R. Klein, Association between serum uric acid level and peripheral arterial disease, Atherosclerosis (2007), Epub.
45. Jakus V. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease. Bratisl. Lek. Listy 101 (2000) 541-551
46. Migdalis I.N., Dimakopoulos N., Kourti A., Tolis A., Koutoulidis K., and Samartzis M. The prevalence of peripheral vascular disease in type 2 diabetic patients with and without proteinuria. Int. Angiol. 13 (1994) 229-232
47. Zander E., Heinke P., Reindel J., Kohnert K.D., Kairies U., Braun J., et al. Peripheral arterial disease in diabetes mellitus type 1 and type 2: are there different risk factors?. Vasa 31 (2002) 249-254
48. Yokoyama H., Aoki T., Imahori M., and Kuramitsu M. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int. 66 (2004) 448-454
49. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death cardiovascular events, and hospedalization. N. Engl. J. Med. 351 (2004) 1296-1305
50. O'Hare A.M., Glidden D.V., Fox C.S., and Hsu C.Y. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 109 (2004) 320-323
51. Hosokawa K., Kuriyama S., Astumi Y., Kaneda S., and Mastuoka K. Incidence of peripheral arteriosclerotic complications of the lower extremities in diabetic patients with chronic renal failure. Ther. Apher. Dial 9 (2005) 161-166
52. Kohlhagen J., and Kelly J. Prevalence of vascular risk factors and vascular disease in predialysis chronic renal failure. Nephrology 8 (2003) 274-279
53. Bruno G., Cavallo-Perin P., Bargero G., Borra M., D'Errico N., Macchia G., et al. Cardiovascular risk profile of type 2 diabetic patients cared for by general practitioners or at a diabetes clinic: a population-based study. J. Clin. Epidemiol. 52 (1999) 413-417
54. Verlato G., Muggeo M., Bonora E., Corbellini M., Bressan F., and de Marco R. Attending the diabetes center is associated with increased 5-year survival probability of diabetic patients: the Verona Diabetes Study. Diabetes Care 19 (1996) 211-213